Jun 7, 2020 | News
The science behind the silent killer. Here is how Inimmune is developing vaccines to help solve the opioid epidemic. Read full article: Science and the Silent Killer
Jun 7, 2020 | News
Bioscience research and development can unlock the economic potential of the Mountain West, providing jobs and substantial economic benefit. Read how Inimmune Corporation in Missoula, Montana is bridging academic research and commercial development with the...
Jun 6, 2020 | News
The University of Montana is a recipient of a $3.3 million dollar contract from the National Institutes of Health to develop a vaccine to treat opioid addiction. Inimmune Corporation will be a collaborator in developing this project. Watch the interview to...
Jun 5, 2020 | News
Inimmune is developing vaccines to treat food allergies. Read about the future prospects of treatments for food allergies here. http://www.kidswithfoodallergies.org/page/food-allergy-developing-new-treatments-current-research.aspx
Oct 25, 2019 | News
Original Article by https://missoulian.com/users/profile/KeilaSzpaller October, 9, 2018 A research center at the University of Montana earned $22.4 million this summer and fall from the National Institutes of Health. “It’s validated that...
